Advanced Medical Solutions Group
AMS · AIM · Health Care · mcap £614m · 282.0p
| Date | Type | Announcement | Day |
|---|---|---|---|
| 13 Oct 26 | Publication of Financing Materials
H.B. Fuller publishes financing materials for recommended acquisition of AMS by cash scheme. |
+0.0% | |
| 06 Oct 26 | Publication of Financing Materials.
Financing materials for H.B. Fuller's recommended cash acquisition of AMS published for debt investors. |
−0.2% | |
| 30 Sep 26 | Publication of Financing Materials
H.B. Fuller publishes financing materials for its recommended £294m cash acquisition of AMS. |
+0.2% | |
| 16 Sep 26 | Results | Half-year Results
H1 2026 revenue up 4% to £115.5m; adjusted EBITDA up 8% but reported profit down 96% due to £12.4m exceptional items. |
+0.2% |
| 01 Sep 26 | Rule 26 Disclosure
AMS and H.B. Fuller enter clean team agreement for integration planning in recommended cash acquisition. |
−0.5% | |
| 12 Aug 26 | Results of Court Meeting and General Meeting
H.B. Fuller acquisition of AMS approved by shareholders at Court and General Meetings held 12 August 2026. |
+0.0% | |
| 20 Jul 26 | Publication of Scheme Document
Scheme Document published for AMS shareholders to vote on H.B. Fuller's recommended cash acquisition. |
+0.7% | |
| 20 Jul 26 | Trading update | Half Year 2026 Trading Update
H1 2026 revenue £115.2m, up 3.9% on prior year, but de-stocking impacted sales. |
+0.7% |
| 25 Jun 26 | Offer | Recommended Cash Acquisition
H.B. Fuller to acquire AMS for 285p per share, valuing the company at £659m, representing a 34.8% premium to the pre-announcement closing price. |
+16.0% |
| 18 Jun 26 | Extension of PUSU Deadline
PUSU deadline for H.B. Fuller takeover approach extended to 2 July 2026 from 18 June. |
+0.4% | |
| 17 Jun 26 | Result of AGM
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the world-leading specialist in tissue-healing technologies, announces that at the Company's Annual General Meeting held today at 11 am at the Offices of Inv |
+5.6% | |
| 21 May 26 | Statement re Advanced Medical Solutions Group plc
H.B. Fuller submitted all-cash proposal for AMS on 30 April; discussions ongoing, firm offer decision due 18 June 2026. |
+3.3% | |
| 21 May 26 | Disclosure Table
The following are today's changes to the Disclosure Table: |
+3.3% | |
| 21 May 26 | Offer | Statement re Possible Offer
H.B. Fuller made unsolicited cash offer proposal on 30 April; discussions ongoing, firm offer decision required by 18 June. |
+3.3% |
| 18 May 26 | Disclosure Table
The following are today's changes to the Disclosure Table: |
−18.4% | |
| 18 May 26 | Response to 2.8 Announcement
TA Associates confirms it does not intend to make an offer for AMS and is bound by Rule 2.8 restrictions. |
−18.4% | |
| 15 May 26 | Offer | No Intention to Make an Offer for AMS
TA Associates confirms it does not intend to make an offer for AMS following earlier takeover approach consideration. |
−3.5% |
| 20 Apr 26 | Disclosure Table
The following are today's changes to the Disclosure Table: |
+16.2% | |
| 20 Apr 26 | Offer | Statement re Possible Offer
AMS in discussions with TA Associates regarding a possible offer for the company. |
+16.2% |
| 18 Mar 26 | Results | Unaudited Preliminary Results
Record revenue of £228.9m, up 29%, with adjusted EBITDA up 24% to £49.9m and dividend increased 10%. |
−0.3% |
| 15 Jan 26 | Trading update | Full Year 2025 Trading Update
Full year 2025 revenues of £228.5m and EBITDA of £49.5-£50.0m, ahead of 2024 driven by surgical products. |
+0.9% |
| 27 Oct 25 | Upcoming Investor Conferences
AMS to attend investor conferences in November and December 2025. |
−1.8% |
Company filings. Not investment advice.